On the other hand, the presence of tumor-infiltrating effector CD8+ T cells was determined in prior studies in human glioma and mouse models to be involved in glioma eradication and to prompt certain anti-tumoral immune responses (8, 9, 32). This evidence concerns the gene CD8A and neoplasm.